Aligos Therapeutics (ALGS) Current Assets (2019 - 2026)
Aligos Therapeutics' Current Assets was $34.68 million in Q3 2026, down 66.5% from $103.44 million a year earlier and down 44.2% from the prior quarter.
Aligos Therapeutics (ALGS) Current Assets (2019 - 2026) Analysis & Trends
At the end of FY2025, Current Assets at Aligos Therapeutics came in at $82.86 million, up 33.3% from FY2024.
- Current Assets shows a five-year compound annual growth rate of -19.8% (FY2020 to FY2025).
- In earlier years, Current Assets was $62.14 million in FY2024 (-56.0%), $141.08 million in FY2023 (+5.6%), $133.55 million in FY2022 (-34.7%) and $204.42 million in FY2021 (-18.2%).
- The Q3 2026 figure marks the lowest quarterly Current Assets in data going back to Q4 2019.
- Compared with a year earlier, Current Assets has declined for three straight quarters, with an average decline of 14.9% over the last eight quarters.
- The best year-over-year quarter for Current Assets over five years was Q4 2025 (growth of 33.3%); the worst was Q3 2026 (a decline of 66.5%).
- Per Business Quant data, ALGS's Current Assets in the three quarters before Q3 2026 was $62.13 million (Q2 2026), $59.63 million (Q1 2026) and $82.86 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 65.26 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 37.48 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 38.94 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 31.45 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 34.36 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 16.55 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 45.01 Bn |
| 10 | Aligos Therapeutics | 21.97 Mn | -314.86 Mn | - | 34.68 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 34.68 Mn |
| Jun 30, 2026 | 62.13 Mn |
| Mar 31, 2026 | 59.63 Mn |
| Dec 31, 2025 | 82.86 Mn |
| Sep 30, 2025 | 103.44 Mn |
| Jun 30, 2025 | 127.94 Mn |
| Mar 31, 2025 | 143.21 Mn |
| Dec 31, 2024 | 62.14 Mn |
| Sep 30, 2024 | 79.82 Mn |
| Jun 30, 2024 | 99.57 Mn |
| Mar 31, 2024 | 118.06 Mn |
| Dec 31, 2023 | 141.08 Mn |
| Sep 30, 2023 | 74.64 Mn |
| Jun 30, 2023 | 94.24 Mn |
| Mar 31, 2023 | 109.43 Mn |
| Dec 31, 2022 | 133.55 Mn |
| Sep 30, 2022 | 150.09 Mn |
| Jun 30, 2022 | 167.69 Mn |
| Mar 31, 2022 | 195.08 Mn |
| Dec 31, 2021 | 204.42 Mn |
Aligos Therapeutics Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=ALGS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "ALGS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=ALGS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();